• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA R2P MISAGO RX SELF-EXPANDING PERIPHERAL STENT; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA R2P MISAGO RX SELF-EXPANDING PERIPHERAL STENT; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number N/A
Device Problem Activation, Positioning or Separation Problem (2906)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/23/2024
Event Type  Injury  
Event Description
The user facility reported that the 7 x 150 misago was deployed in a proximal superficial femoral artery (sfa) without difficulty.The medical doctor (md) then tried to pass an 8 x 80 balloon over the gwa.035 and the proximal edge of the misago would not allow the balloon to cross.The md tried smaller balloons on the.035 platform, and none would pass the proximal portion of the stent.Eventually the md changed out the.035 system for an.018 platform and was able to get a.018 balloon across the proximal portion of the stent and inflate and expand the stent and allowed him to complete the case.The md had to use additional.018 platform equipment and an additional 7 x 40 misago to deploy inside of the proximal portion of the 7 x 150 misago to ensure that it would stay open.The estimated blood loss was less than 250cc's.The reported event did result in patient injury/medical or surgical intervention.The patient's medical history was peripheral artery disease (pvd), coronary artery disease (cad).There is not a direct allegation that the reported device caused or contributed to patient injury and/or need for medical intervention.Additional information was received on 25 jan 2024: the patient was stable the entire procedure.The procedure performed was left leg angiogram, with aspiration of thrombus, drug coated balloon, then stenting.The issue caused by the stent did delay the procedure and also required the patient to receive additional medication for the increased length of the procedure.The patient's anatomy did not seem to be the case.Up until we put the stent in, we were able to put multiple devices through that area without difficulty.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
R2P MISAGO RX SELF-EXPANDING PERIPHERAL STENT
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, 418
JA  418
MDR Report Key18743154
MDR Text Key335813462
Report Number2243441-2024-00001
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 02/20/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue NumberSXR07150R
Device Lot Number230208
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA02/20/2024
Distributor Facility Aware Date01/23/2024
Device Age11 MO
Event Location Hospital
Date Report to Manufacturer01/26/2024
Initial Date Manufacturer Received Not provided
Initial Date FDA Received02/20/2024
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
7 X 40 MISAGO; ADDITIONAL .018 PLATFORM EQUPIMENT
Patient Outcome(s) Required Intervention;
-
-